Search Count: 10
 |
Covalent Complex Of Sars-Cov Main Protease With N-[(2S)-1-({(2S,3S)-3,4-Dihydroxy-1-[(3S)-2-Oxopyrrolidin-3-Yl]Butan-2-Yl}Amino)-4-Methyl-1-Oxopentan-2-Yl]-4-Methoxy-1H-Indole-2-Carboxamide
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: V2M
 |
Covalent Complex Of Sars-Cov-2 Main Protease With N-[(2S)-1-({(2S,3S)-3,4-Dihydroxy-1-[(3S)-2-Oxopyrrolidin-3-Yl]Butan-2-Yl}Amino)-4-Methyl-1-Oxopentan-2-Yl]-4-Methoxy-1H-Indole-2-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: V2M, EDO |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: V2M, EDO
 |
Covalent Complex Of Sars-Cov Main Protease With 4-Methoxy-N-[(2S)-4-Methyl-1-Oxo-1-({(2S)-3-Oxo-1-[(3S)-2-Oxopyrrolidin-3-Yl]Butan-2-Yl}Amino)Pentan-2-Yl]-1H-Indole-2-Carboxamide
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION Resolution:1.38 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: V3D, EDO |
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: V3D, EDO
 |
Covalent Complex Of Sars-Cov Main Protease With Ethyl (4R)-4-({N-[(4-Methoxy-1H-Indol-2-Yl)Carbonyl]-L-Leucyl}Amino)-5-[(3S)-2-Oxopyrrolidin-3-Yl]Pentanoate
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: EDO, V34 |
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: EDO, V34
 |
Miniature Tgf-Beta2 3-Mutant Monomer
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2017-03-01 Classification: CYTOKINE |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2017-03-01
 |
Derivative Of Mouse Tgf-Beta2, With A Deletion Of Residues 52-71 And K25R, R26K, L51R, A74K, C77S, L89V, I92V, K94R T95K, I98V Single Amino Acid Substitutions, Bound To Human Tgf-Beta Type Ii Receptor Ectodomain Residues 15-130
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2017-03-01 Classification: TRANSFERASE/CYTOKINE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-01
 |
Structure Of Tgf-Beta2 Derivative With Deletion Of Residues 52-71 And 10 Single Amino Acid Mutations (Mmtgf-Beta2-7M)
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2017-03-01 Classification: CYTOKINE Ligands: CA |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2017-03-01
Ligands: CA
 |
Solution Nmr Structure Of The Membrane Localization Domain From Pasteurella Multocida Toxin
|
Organism: Pasteurella multocida
Method: SOLUTION NMR
Release Date: 2016-12-07
 |
Solution Nmr Structure Of The Membrane Localization Domain From The Ras/Rap1-Specific Endopeptidase (Rrsp) Of The Vibrio Vulnificus Multifunctional Autoprocessing Repeats-In-Toxins (Martx) Toxin
|
Organism: Vibrio vulnificus
Method: SOLUTION NMR
Release Date: 2016-12-07
 |
Type 2 Rhinovirus 3C Protease With Ag7088 Inhibitor
Organism: Human rhinovirus 2
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 1999-09-20 Classification: HYDROLASE Ligands: AG7 |
Organism: Human rhinovirus 2
Method: X-RAY DIFFRACTION
Release Date: 1999-09-20
Ligands: AG7